Melanomas use Wnt5α to upregulate lipid uptake and carnitine palmitoyltransferase-1A (CPT1A) in DCs, driving fatty acid oxidation and oxidative phosphorylation, leading to the establishment of a site with immune privilege [37]. The gene discussed is CPT1A; the disease is melanoma.